Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by Exponentialpickon Feb 23, 2019 11:50pm

149 Views

Post# 29405312

RE:Near term futur

Intrinsic value at $135 million net income would equate to a little over $1.00 eps, using Benjamin Grahams intrinsic value formula at a 10% growth rate equals a $29.7 price per share. Use a high end 20% growth rate and we are at $50 per share. Conclusion: load the f*cking boat.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages